Comparison of Hemodynamic Stability With 0.75percent and 0.5percent Hyperbaric Bupivacaine During Spinal Anesthesia in Cystoscopic Procedures

ConditionCystoscopy
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPAEC General Hospital, Islamabad

About this trial

Purpose:The aim of this study is to determine the intrathecal Bupivacaine concentration(0.5% vs 0.75%) with better anesthesia and little hemodynamic disturbance during cystoscopic procedures.In comparing these bupivacaine concentrations ,the result would be expected to enhance safer spinal anesthesia practices ,minimizing the use of vasopressors in urological surgeries.OBJECTIVE:To compare and analyze the frequency and average chages of post spinal hemodynamic instability in terms of hypotension and bradycardia with 0.75% hyperbaric bupivacaine and 0.55 hyperbaric bupivacaine in patients presenting for cystoscopic procedures.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-80 years. American society of Anesthesiologist(ASA) physical status I-II. Sceduled for elective cystoscopic procedures under spinal anesthesia.

Disqualifiers

Patient refusal. Contraindication to spinal anesthesia(e.g coagulopathy ,infection at injection site).

Trial design

Design model

Parallel

Treatments tested in this trial

  • 0.5% Hyperbaric Bupivicaine

    Drug

    0.5% hyperbaric bupivacaine will be administered intrathecally for spinal anesthesia in patients undergoing cystoscopic procedures.hemodynamic parameters,systolic blood pressure and heart rate will be monitored, and its effects on hemodynamic stability will be assesed and compared with other intervention.

  • 0.75% hyperbaric bupivacaine

    Drug

    0.75% hyperbaric bupivacaine will be administered intrathecally duringspinal anesthesia in patients undergoing cystoscopic procedures.hemodynamic parameters will be monitored ,and its effects on hemodynamic stability will be assesed and compared with 0.5% bupivacaine.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: 0.5% hyperbaric bupivacaine groupActive comparator 1 intervention
Group B: 0.75% hyperbaric bupivacaine groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Measurement of frequency and mean changes in systolic blood pressure and heart rate

Measurement of frequency and mean changes in systolic blood pressure(to assess hypotension) and heart rate(to assess bradycardia)will be recorded and analyzed to evaluate the hemodynamic effects of 0.5% vs 0.75% hyperbaric bupivacaine in patients undergoing cystoscopic procedures under spinal anesthesia.

Time frame
From institution of spinal block upto 30 minutes

Secondary outcomes

1

Requirement for Vasopressors, Atropine ,and Intravenous fluids

The need for vasopressors,atropine and iv fluids to manage hemodynamic instability during spinal anesthesia in patients undergoing cystoscopic procedures with 0.5% vs 0.75% hyperbaric bupivacaine shall also be recorded and compared.

Time frame
From institution of spinal block upto 30 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: